Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -211.18 is 100% above its 5-year average of -22462429.83, near the high end of its 5-year range (-125727793.00–922390.00).
99.95% above its 12-month average of -432751.00.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -5.31.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 28 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:20:45.146Z. Historical observations retain their original dates. Historical series through 2023-08-10.
EARNINGS PER SHARE (EPS)
-211.18
EARNINGS PER SHARE (EPS) AVG TTM
-432751.00
EARNINGS PER SHARE (EPS) AVG 3Y
-875189.50
EARNINGS PER SHARE (EPS) AVG 5Y
-22462429.83
EARNINGS PER SHARE (EPS) AVG 10Y
-23839087.00
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+99.95%
CURRENT VS 3Y AVG
+99.98%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aptevo Therapeutics Inc.
Market Cap
$3.94M
Earnings Per Share (EPS)
-211.18
TTM Avg
-432751.00
3Y Avg
-875189.50
5Y Avg
-22462429.83
Market Cap
$4.18M
Earnings Per Share (EPS)
N/A
TTM Avg
-60.73
3Y Avg
-46926.80
5Y Avg
-32538.00
Market Cap
$4.32M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.88
3Y Avg
-0.66
5Y Avg
-0.44
Market Cap
$3.48M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.47M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$4.41M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$4.42M
Earnings Per Share (EPS)
-9.39
TTM Avg
-11.95
3Y Avg
-11.32
5Y Avg
-8.88
Market Cap
$3.44M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.94M | -211.18 | -432751.00 | -875189.50 | -22462429.83 |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | -60.73 | -46926.80 | -32538.00 |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -0.76 | -0.88 | -0.66 | -0.44 |
| Evogene Ltd. (EVGN)vs › | $3.48M | -0.91 | -1.99 | -3.92 | -2.83 |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -6.76 | -8.05 | -9.85 | -9.67 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -18.85 | -47.63 | -99.69 | -316.96 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -9.39 | -11.95 | -11.32 | -8.88 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | -11.70 | -48.19 | -238.41 | -340.02 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -4.39 | -44.24 | -644.57 | -610.60 |
Trailing EPS (TTM)
$-211.18
Forward EPS (Est.)
$-17.04
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | -31458.00 |
| 2023-12-31 | -834044.00 |
| 2022-12-31 | 922390.00 |
| 2021-12-31 | -3557646.00 |
| 2020-12-31 | -5546028.00 |
| 2019-12-31 | -125727793.00 |
| 2018-12-31 | -19578811.00 |
| 2017-12-31 | -17584638.00 |
| 2016-12-31 | -45538416.00 |
| 2015-12-31 | -24041001.00 |
| 2014-12-31 | -20712512.00 |
| 2013-12-31 | 0.00 |
